Zurück zu Projekte

13877.1;10 PFLS-LS

Development of a 18F-PET Folate Tracer for Diagnosis and Therapy Planning of Cancer Diseases

Zusammenfassung

Development of a 18F-PET Folate Tracer for Diagnosis and Therapy Planning of Cancer Diseases

Weitere Texte

Abstract

Non-invasive, nuclear imaging techniques such as positron emission tomography (PET) are crucial for cancer diagnosis, treatment planning and monitoring. The folate receptor (FR) is a promising cancer-related target because of its overexpression in a wide variety of tumor types. We will test the first PET-folate tracer in a pilot study in patients. The novel radiotracer is expected to be of major clinical and health economical relevance as it serves for diagnostic purposes and also for identification of patients, who may profit from FR-targeting therapies.

Beteiligte

Roger Schibli

Kontaktperson

roger.schibli@pharma.ethz.ch

ETH Zürich Roger Schibli Wolfgang-Pauli-Strasse 10 Institute of Pharmaceutical Science 8093 Zürich ZH CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2012-08-31
Enddatum
2015-11-11
Bewilligte Gesamtkosten
CHF 142080.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Nicht aufteilbare / nicht zuteilbare Forschung

Forschungsdisziplinen

  • P004 Biochemistry, Metabolism 100.0%